Witjes JA - Search Results

1

High-grade Ta urothelial carcinoma and carcinoma in situ of the bladder.

Sylvester RJ, van der Meijden A, Witjes JA, Jakse G, Nonomura N, Cheng C, Torres A, Watson R, Kurth KH. Sylvester RJ, et al. Among authors: witjes ja. Urology. 2005 Dec;66(6 Suppl 1):90-107. doi: 10.1016/j.urology.2005.06.135. Urology. 2005. PMID: 16399418 Review.

2

Treatment of carcinoma in situ of the urethra with intraurethral instillations of bacillus Calmette-Guérin. Case report and review of literature.

Witjes JA, Debruyne FM, van der Meijden AP. Witjes JA, et al. Eur Urol. 1991;20(2):170-2. doi: 10.1159/000471691. Eur Urol. 1991. PMID: 1752279 Review.

3

Expression of markers for transitional cell carcinoma in normal bladder mucosa of patients with bladder cancer.

Witjes JA, Umbas R, Debruyne FM, Schalken JA. Witjes JA, et al. J Urol. 1995 Dec;154(6):2185-9. J Urol. 1995. PMID: 7500486

4

Risk factors in carcinoma in situ of the urinary bladder. Dutch South East Cooperative Urological Group.

van Gils-Gielen RJ, Witjes WP, Caris CT, Debruyne FM, Witjes JA, Oosterhof GO. van Gils-Gielen RJ, et al. Among authors: witjes wp, witjes ja. Urology. 1995 Apr;45(4):581-6. doi: 10.1016/s0090-4295(99)80047-8. Urology. 1995. PMID: 7716838 Clinical Trial.

5

A randomized study of intravesical mitomycin C, bacillus Calmette-Guerin Tice and bacillus Calmette-Guerin RIVM treatment in pTa-pT1 papillary carcinoma and carcinoma in situ of the bladder.

Vegt PD, Witjes JA, Witjes WP, Doesburg WH, Debruyne FM, van der Meijden AP. Vegt PD, et al. Among authors: witjes wp, witjes ja. J Urol. 1995 Mar;153(3 Pt 2):929-33. J Urol. 1995. PMID: 7853577 Clinical Trial.

6

Use of maintenance intravesical bacillus Calmette-Guérin (BCG), with or without intradermal BCG, in patients with recurrent superficial bladder cancer. Long-term follow-up of a randomized phase 2 study.

Witjes JA, Fransen MP, van der Meijden AP, Doesburg WH, Debruyne FM. Witjes JA, et al. Urol Int. 1993;51(2):67-72. doi: 10.1159/000282516. Urol Int. 1993. PMID: 8351757 Clinical Trial.

7

Intravesical instillation therapy: alternative treatments.

Debruyne FM, van der Meijden AP, Witjes JA. Debruyne FM, et al. Among authors: witjes ja. Recent Results Cancer Res. 1993;126:119-25. doi: 10.1007/978-3-642-84583-3_11. Recent Results Cancer Res. 1993. PMID: 8456182 Review. No abstract available.

8

Treatment of carcinoma in situ of the urinary bladder with bropirimine.

Witjes JA. Witjes JA. Eur Urol. 1997;31 Suppl 1:27-30. doi: 10.1159/000474528. Eur Urol. 1997. PMID: 9076483 Review.

9

The Bard BTA test: its mode of action, sensitivity and specificity, compared to cytology of voided urine, in the diagnosis of superficial bladder cancer.

Schamhart DH, de Reijke TM, van der Poel HG, Witjes JA, de Boer EC, Kurth K, Schalken JA. Schamhart DH, et al. Among authors: witjes ja. Eur Urol. 1998 Aug;34(2):99-106. doi: 10.1159/000019692. Eur Urol. 1998. PMID: 9693243 Clinical Trial.

10

Long-term follow-up of an EORTC randomized prospective trial comparing intravesical bacille Calmette-Guérin-RIVM and mitomycin C in superficial bladder cancer. EORTC GU Group and the Dutch South East Cooperative Urological Group. European Organisation for Research and Treatment of Cancer Genito-Urinary Tract Cancer Collaborative Group.

Witjes JA, v d Meijden AP, Collette L, Sylvester R, Debruyne FM, van Aubel A, Witjes WP. Witjes JA, et al. Among authors: witjes wp. Urology. 1998 Sep;52(3):403-10. doi: 10.1016/s0090-4295(98)00212-x. Urology. 1998. PMID: 9730451 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

507 results

Search Page